Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
A clinical trial is testing a new device to reduce chest pain in adults with chronic angina unresponsive to standard treatment.
A clinical trial called COSIRA II is enrolling adults with ongoing chronic angina despite maximum medication therapy to test an investigational device aimed at reducing chest pain and improving symptoms.
About 11 million Americans have angina, often due to reduced heart blood flow, and up to 40% still experience symptoms after standard treatments.
The study seeks to evaluate the device’s safety and effectiveness, offering potential new options for patients with persistent symptoms.
Participation is available through specific sites, and more details are available via Shockwave Medical.
The device is for research use only.
Un ensayo clínico está probando un nuevo dispositivo para reducir el dolor de pecho en adultos con angina crónica que no responde al tratamiento estándar.